Carrot RG-I Reduces Interindividual Differences between 24 Adults through Consistent Effects on Gut Microbiota Composition and Function Ex Vivo
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
The human gut microbiota is characterized by large interpersonal differences, which are not only linked to health and disease but also determine the outcome of nutritional interventions. In line with the growing interest for developing targeted gut microbiota modulators, the selectivity of a carrot-derived rhamnogalacturonan I (cRG-I) was compared to substrates with demonstrated low (inulin, IN) and high selectivity (xanthan, XA), at a human equivalent dose (HED) of 1.5 g/d. The high throughput of the ex vivo SIFR® technology, validated to generate predictive insights for clinical findings, enabled the inclusion of 24 human adults. Such an unprecedented high number of samples in the context of in vitro gut microbiota modelling allowed a coverage of clinically relevant interpersonal differences in gut microbiota composition and function. A key finding was that cRG-I supplementation (already at an HED of 0.3 g/d) lowered interpersonal compositional differences due to the selective stimulation of taxa that were consistently present among human adults, including OTUs related to Bacteroides dorei/vulgatus and Bifidobacterium longum (suspected keystone species), Bacteroides thetaiotaomicron, Bifidobacterium adolescentis and butyrate-producing taxa such as Blautia sp., Anaerobutyricum hallii, and Faecalibacterium prausnitzii. In contrast, both IN and XA treatments increased interpersonal compositional differences. For IN, this followed from its low specificity. For XA, it was rather the extremely high selectivity of XA fermentation that caused large differences between 15 responders and 9 nonresponders, caused by the presence/absence of highly specific XA-fermenting taxa. While all test compounds significantly enhanced acetate, propionate, butyrate, and gas production, cRG-I resulted in a significantly higher acetate (+40%), propionate (+22%), yet a lower gas production (–44%) compared to IN. cRG-I could thus result in overall more robust beneficial effects, while also being better tolerated. Moreover, owing to its remarkable homogenization effect on microbial composition and metabolite production, cRG-I could lead to more predictable outcomes compared to substrates that are less specific or overly specific.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Despite marked SCFA production, cRG-I leads to lower gas production compared to other commonly used prebiotics like inulin, suggesting superior tolerability [73,133]”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [73]
The cited source says what the claim attributes to it.
In the citing paper
“This soluble fiber from carrot pomace, rich in complex pectin domains (RG-I), selectively modulates gut microbiota and enhances SCFA production, notably acetate and propionate [72,73,133]”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“Treatment effects were compared with the NSC using a repeated measures ANOVA (based on paired testing) and p-values were corrected with Benjamini–Hochberg’s method [38] (FDR = 0.”
MethodEnterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634 · cited 1×
“Despite being defined as substrates that are selectively utilized by host microorganisms (thus conferring a health benefit) [23], recent reports describe the low selectivity by which several traditional prebiotics impact the human gut microbiota [24,25]; e.”
BackgroundGut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
mixOmics: An R package for ‘omics feature selection and multiple data integration
Rohart, F., Gautier, B., Singh, A., & Lê Cao, K.-A. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005752 · Cited by 4,056 · cited 1×
“org, accessed on 23 November 2022) [37].”
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1237-9 · Cited by 3,143
Formation of propionate and butyrate by the human colonic microbiota
Louis, P., & Flint, H. J. (2017) · Environmental Microbiology · doi:10.1111/1462-2920.13589 · Cited by 3,028 · cited 1×
“thetaiotaomicron) [10], acetateproducing Bifidobacteriaceae (B.”
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,816
Population-level analysis of gut microbiome variation
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., et al. (2016) · Science · doi:10.1126/science.aad3503 · Cited by 2,400 · cited 1×
“While the exact classification of gut microbiota in distinct gut enterotypes is still evolving [17,18], it is clear that Prevotella, Bacteroides and Ruminococcus are three main contributors to the microbiota variation in healthy subjects [19].”
BackgroundGut microbiome and health: mechanistic insights
de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022) · Gut · doi:10.1136/gutjnl-2021-326789 · Cited by 2,388
Probiotics and prebiotics in intestinal health and disease: from biology to the clinic
Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R., & Rastall, R. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0173-3 · Cited by 2,059 · cited 2×
“In line with the recently proposed classification of fibres based on their “specificity” [21,22], cRG-I displays properties of a medium-high specificity fibre, thus reliably increasing the abundance of beneficial bacterial species commonly found in the gut microbiota of healthy adults.”
BackgroundGut microbiota and IBD: causation or correlation?
Ni, J., Wu, G. D., Albenberg, L., & Tomov, V. T. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.88 · Cited by 1,778 · cited 1×
“Over the past decades, the human gut microbiota has been related with human health and, when aberrant, to metabolic disorders (obesity, type 2 diabetes, nonalcoholic liver disease, cardiometabolic diseases) [1], inflammatory bowel diseases [2,3], cancer [4], celiac disease [5], and even brain-related conditions [6].”
BackgroundRivière, A., Selak, M., Lantin, D., Leroy, F., & De Vuyst, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00979 · Cited by 1,726 · cited 2×
“Interestingly, cRG-I thus combines the property of leading to a pronounced production of SCFA [8,9] combined with a low gas production that should translate in a better tolerability.”
BackgroundCounting the Uncountable: Statistical Approaches to Estimating Microbial Diversity
Hughes, J. B., Hellmann, J. J., Ricketts, T. H., & Bohannan, B. J. M. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.10.4399-4406.2001 · Cited by 1,296 · cited 1×
“As compared to other indices, this index estimates the number of missing OTUs (and thus “counts the uncountable”) [36].”
ResultGut Bacteroides species in health and disease
Zafar, H., & Saier, M. H. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1848158 · Cited by 1,233
Quantitative microbiome profiling links gut community variation to microbial load
Vandeputte, D., Kathagen, G., D’hoe, K., Vieira-Silva, S., Valles-Colomer, M., Sabino, J., Wang, J., Tito, R. Y., De Commer, L., Darzi, Y., et al. (2017) · Nature · doi:10.1038/nature24460 · Cited by 1,218 · cited 1×
“While the exact classification of gut microbiota in distinct gut enterotypes is still evolving [17,18], it is clear that Prevotella, Bacteroides and Ruminococcus are three main contributors to the microbiota variation in healthy subjects [19].”
BackgroundEnterotypes in the landscape of gut microbial community composition
Costea, P. I., Hildebrand, F., Arumugam, M., Bäckhed, F., Blaser, M. J., Bushman, F. D., de Vos, W. M., Ehrlich, S. D., Fraser, C. M., Hattori, M., et al. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0072-8 · Cited by 1,138 · cited 1×
“While the exact classification of gut microbiota in distinct gut enterotypes is still evolving [17,18], it is clear that Prevotella, Bacteroides and Ruminococcus are three main contributors to the microbiota variation in healthy subjects [19].”
BackgroundDuncan, S. H., Louis, P., & Flint, H. J. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.10.5810-5817.2004 · Cited by 1,129
Microbial Regulation of Host Physiology by Short-chain Fatty Acids
van der Hee, B., & Wells, J. M. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.02.001 · Cited by 980
Recognition and Degradation of Plant Cell Wall Polysaccharides by Two Human Gut Symbionts
Martens, E. C., Lowe, E. C., Chiang, H., Pudlo, N. A., Wu, M., McNulty, N. P., Abbott, D. W., Henrissat, B., Gilbert, H. J., Bolam, D. N., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001221 · Cited by 860 · cited 2×
“While Bacteroides species are generally known to possess a broad range of carbohydrate-active enzymes (CAZymes) within their polysaccharide utilization loci (PUL) [46,47], B. dorei/vulgatus seems to be the most competitive amongst Bacteroides species to ferment cRG-I.”
BackgroundThe role of pH in determining the species composition of the human colonic microbiota
Duncan, S. H., Louis, P., Thomson, J. M., & Flint, H. J. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01931.x · Cited by 786 · cited 1×
“Such a lower pH likely explains the stronger effects of IN dosed at levels above 10 g/d on acid-tolerant Bifidobacteriaceae in contrast to Bacteroides species that thrive better at higher pH [55].”
BackgroundDuncan, S. H., Hold, G. L., Harmsen, H. J. M., Stewart, C. S., & Flint, H. J. (2002) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/00207713-52-6-2141 · Cited by 708
Complex pectin metabolism by gut bacteria reveals novel catalytic functions
Ndeh, D., Rogowski, A., Cartmell, A., Luis, A. S., Baslé, A., Gray, J., Venditto, I., Briggs, J., Zhang, X., Labourel, A., et al. (2017) · Nature · doi:10.1038/nature21725 · Cited by 639 · cited 2×
“While Bacteroides species are generally known to possess a broad range of carbohydrate-active enzymes (CAZymes) within their polysaccharide utilization loci (PUL) [46,47], B. dorei/vulgatus seems to be the most competitive amongst Bacteroides species to ferment cRG-I.”
BackgroundVan den Abbeele, P., Belzer, C., Goossens, M., Kleerebezem, M., De Vos, W. M., Thas, O., De Weirdt, R., Kerckhof, F.-M., & Van de Wiele, T. (2013) · The ISME Journal · doi:10.1038/ismej.2012.158 · Cited by 638
Yoshida, N., Emoto, T., Yamashita, T., Watanabe, H., Hayashi, T., Tabata, T., Hoshi, N., Hatano, N., Ozawa, G., Sasaki, N., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.033714 · Cited by 619
Prebiotic inulin-type fructans induce specific changes in the human gut microbiota
Vandeputte, D., Falony, G., Vieira-Silva, S., Wang, J., Sailer, M., Theis, S., Verbeke, K., & Raes, J. (2017) · Gut · doi:10.1136/gutjnl-2016-313271 · Cited by 554 · cited 1×
“As a remark, the stimulation of Bifidobacteriaceae is the most pronounced microbiota change commonly induced by IN in clinical studies [53].”
BackgroundBerni Canani, R., Sangwan, N., Stefka, A. T., Nocerino, R., Paparo, L., Aitoro, R., Calignano, A., Khan, A. A., Gilbert, J. A., & Nagler, C. R. (2016) · The ISME Journal · doi:10.1038/ismej.2015.151 · Cited by 525
mixOmics : an R package for ‘omics feature selection and multiple data integrationPreprint
Rohart, F., Gautier, B., Singh, A., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/108597 · Cited by 442
Absolute quantification of microbial taxon abundances
Props, R., Kerckhof, F.-M., Rubbens, P., De Vrieze, J., Hernandez Sanabria, E., Waegeman, W., Monsieurs, P., Hammes, F., & Boon, N. (2017) · The ISME Journal · doi:10.1038/ismej.2016.117 · Cited by 379
Gut microbiome and its role in colorectal cancer
Rebersek, M. (2021) · BMC Cancer · doi:10.1186/s12885-021-09054-2 · Cited by 355 · cited 1×
“Over the past decades, the human gut microbiota has been related with human health and, when aberrant, to metabolic disorders (obesity, type 2 diabetes, nonalcoholic liver disease, cardiometabolic diseases) [1], inflammatory bowel diseases [2,3], cancer [4], celiac disease [5], and even brain-related conditions [6].”
BackgroundVan den Abbeele, P., Grootaert, C., Marzorati, M., Possemiers, S., Verstraete, W., Gérard, P., Rabot, S., Bruneau, A., El Aidy, S., Derrien, M., et al. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.00759-10 · Cited by 345
Interindividual variability in gut microbiota and host response to dietary interventions
Healey, G. R., Murphy, R., Brough, L., Butts, C. A., & Coad, J. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux062 · Cited by 292 · cited 3×
“These interpersonal differences are clinically relevant as they impact the outcome of interventions [13,14].”
BackgroundLavelle, A., Lennon, G., O'Sullivan, O., Docherty, N., Balfe, A., Maguire, A., Mulcahy, H. E., Doherty, G., O'Donoghue, D., Hyland, J., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307873 · Cited by 280 · cited 1×
“, the composition of the gut microbiota and the prevalence of keystone species is, however, prone to major interpersonal differences [12].”
BackgroundVan den Abbeele, P., Gérard, P., Rabot, S., Bruneau, A., El Aidy, S., Derrien, M., Kleerebezem, M., Zoetendal, E. G., Smidt, H., Verstraete, W., et al. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02533.x · Cited by 256
Recent Development of Probiotic Bifidobacteria for Treating Human Diseases
Chen, J., Chen, X., & Ho, C. L. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.770248 · Cited by 241 · cited 1×
“adolescentis strains as probiotics [60].”
The Association Between the Gut Microbiota and Parkinson’s Disease, a Meta-Analysis
Shen, T., Yue, Y., He, T., Huang, C., Qu, B., Lv, W., & Lai, H.-Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.636545 · Cited by 219 · cited 1×
“Over the past decades, the human gut microbiota has been related with human health and, when aberrant, to metabolic disorders (obesity, type 2 diabetes, nonalcoholic liver disease, cardiometabolic diseases) [1], inflammatory bowel diseases [2,3], cancer [4], celiac disease [5], and even brain-related conditions [6].”
BackgroundNguyen, N. K., Deehan, E. C., Zhang, Z., Jin, M., Baskota, N., Perez-Muñoz, M. E., Cole, J., Tuncil, Y. E., Seethaler, B., Wang, T., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00887-w · Cited by 189 · cited 1×
“These interpersonal differences are clinically relevant as they impact the outcome of interventions [13,14].”
BackgroundInsights into endogenous Bifidobacterium species in the human gut microbiota during adulthood
Derrien, M., Turroni, F., Ventura, M., & van Sinderen, D. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.04.004 · Cited by 183
Caio, G., Lungaro, L., Segata, N., Guarino, M., Zoli, G., Volta, U., & De Giorgio, R. (2020) · Nutrients · doi:10.3390/nu12061832 · Cited by 176 · cited 1×
“Over the past decades, the human gut microbiota has been related with human health and, when aberrant, to metabolic disorders (obesity, type 2 diabetes, nonalcoholic liver disease, cardiometabolic diseases) [1], inflammatory bowel diseases [2,3], cancer [4], celiac disease [5], and even brain-related conditions [6].”
BackgroundNew View on Dietary Fiber Selection for Predictable Shifts in Gut Microbiota
Cantu-Jungles, T. M., & Hamaker, B. R. (2020) · mBio · doi:10.1128/mbio.02179-19 · Cited by 161 · cited 5×
“, that are selectively fermented by commonly present beneficial commensal microorganisms, thus minimizing interpersonal differences and causing more predictable outcomes of interventions [14,24,25].”
BackgroundResultInfluentialSummer Meeting 2013: growth and physiology of bifidobacteria
Vuyst, L. D., Moens, F., Selak, M., Rivière, A., & Leroy, F. (2013) · Journal of Applied Microbiology · doi:10.1111/jam.12415 · Cited by 137
Shetty, S. A., Zuffa, S., Bui, T. P. N., Aalvink, S., Smidt, H., & de Vos, W. M. (2018) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.003041 · Cited by 137 · cited 1×
“adolescentis) [40], and butyrate-producing species such as Anaerobutyricum hallii [41,42], Blautia sp.”
BackgroundBifidobacterial Dialogue With Its Human Host and Consequent Modulation of the Immune System
Alessandri, G., Ossiprandi, M. C., MacSharry, J., van Sinderen, D., & Ventura, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02348 · Cited by 128
Tolerance of low-digestible carbohydrates: a general view
Livesey, G. (2001) · British Journal of Nutrition · doi:10.1079/bjn2000257 · Cited by 127 · cited 1×
“upon intake of IN (or other fructans such as FOS) due to a rapid colonic fermentation has been observed before and could result in limited tolerance at high doses [66,67].”
BackgroundPlant Glycan Metabolism by Bifidobacteria
Kelly, S. M., Muñoz-Muñoz, J., & van Sinderen, D. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.609418 · Cited by 121
Wong, C. B., Odamaki, T., & Xiao, J. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa010 · Cited by 114
Rajilić-Stojanović, M. D., Maathuis, A. J. H., Heilig, H. G. H. J., Venema, K., de Vos, W. M., & Smidt, H. (2010) · Microbiology · doi:10.1099/mic.0.042044-0 · Cited by 111
Cantu-Jungles, T. M., Bulut, N., Chambry, E., Ruthes, A., Iacomini, M., Keshavarzian, A., Johnson, T. A., & Hamaker, B. R. (2021) · mBio · doi:10.1128/mbio.01028-21 · Cited by 107 · cited 5×
“, that are selectively fermented by commonly present beneficial commensal microorganisms, thus minimizing interpersonal differences and causing more predictable outcomes of interventions [14,24,25].”
BackgroundResultInfluentialMarasco, G., Cirota, G. G., Rossini, B., Lungaro, L., Biase, A. R. D., Colecchia, A., Volta, U., GIORGIO, R. D., Festi, D., & Caio, G. (2020) · Nutrients · doi:10.3390/nu12092674 · Cited by 101 · cited 2×
“In line with the recently proposed classification of fibres based on their “specificity” [21,22], cRG-I displays properties of a medium-high specificity fibre, thus reliably increasing the abundance of beneficial bacterial species commonly found in the gut microbiota of healthy adults.”
BackgroundLin, C., Lin, Y., Zhang, H., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2022) · Nutrients · doi:10.3390/nu14071498 · Cited by 101
Metabolism of a plant derived galactose‐containing polysaccharide by Bifidobacterium breve UCC2003
Motherway, M. O., Fitzgerald, G. F., & van Sinderen, D. (2010) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2010.00218.x · Cited by 96
Tolerance of Probiotics and Prebiotics
Marteau, P. R., & Seksik, P. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000128929.37156.a7 · Cited by 96 · cited 1×
“upon intake of IN (or other fructans such as FOS) due to a rapid colonic fermentation has been observed before and could result in limited tolerance at high doses [66,67].”
BackgroundMechanistic insights into consumption of the food additive xanthan gum by the human gut microbiota
Ostrowski, M. P., Rosa, S. L. L., Kunath, B. J., Robertson, A., Pereira, G. V., Hagen, L. H., Varghese, N. J., Qiu, L., Yao, T., Flint, G., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01093-0 · Cited by 93 · cited 2×
“(2022) [26], who demonstrated an uncultured Ruminococcaceae species (R.”
BackgroundEvolving trends in next-generation probiotics: a 5W1H perspective
Almeida, D., Machado, D., Andrade, J. C., Mendo, S., Gomes, A. M., & Freitas, A. C. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1599812 · Cited by 92
Dietary pectic substances enhance gut health by its polycomponent: A review
Wu, D., Ye, X., Linhardt, R. J., Liu, X., Zhu, K., Yu, C., Ding, T., Liu, D., He, Q., & Chen, S. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12723 · Cited by 87 · cited 1×
“Amongst strategies that aim to improve human health by targeting the gut microbiota, dietary fibres such as pectin-derived polysaccharides [20] and prebiotics are gaining increasing interest [21,22].”
BackgroundBridging preclinical and clinical gut microbiota research using the ex vivo SIFR® technology
den Abbeele, P. V., Deyaert, S., Thabuis, C., Perreau, C., Bajic, D., Wintergerst, E., Joossens, M., Firrman, J., Walsh, D. M., & Baudot, A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1131662 · Cited by 75 · cited 1×
“Second, a value of a given taxonomic group below the limit of detection (LOD) was considered equal to the overall LOD according to the procedure elaborated by Van den Abbeele et al. (2023) [35].”
MethodSelf-citationVan den Abbeele, P., Verstrepen, L., Ghyselinck, J., Albers, R., Marzorati, M., & Mercenier, A. (2020) · Nutrients · doi:10.3390/nu12071917 · Cited by 73
Self-citationArmet, A. M., Deehan, E. C., Thöne, J. V., Hewko, S., & Walter, J. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz074 · Cited by 68 · cited 1×
“They are, for instance, recognized as a key contributor for the inconsistent reports on the benefits of fibre intake [15].”
BackgroundAnaerobic single‐cell dispensing facilitates the cultivation of human gut bacteria
Afrizal, A., Hitch, T. C. A., Viehof, A., Treichel, N. S., Riedel, T., Abt, B., Buhl, E. M., Kohlheyer, D., Overmann, J., & Clavel, T. (2022) · Environmental Microbiology · doi:10.1111/1462-2920.15935 · Cited by 68
Maturana, J. L., & Cárdenas, J. P. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.660920 · Cited by 65 · cited 1×
“[43,44], and Faecalibacterium prausnitzii [45].”
A Novel Immunobiotics Bacteroides dorei Ameliorates Influenza Virus Infection in Mice
Song, L., Huang, Y., Liu, G., Li, X., Xiao, Y., Liu, C., Zhang, Y., Li, J., Xu, J., Lu, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.828887 · Cited by 56
Donnell, M. M. O., Rea, M. C., Shanahan, F., & Ross, R. P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01844 · Cited by 55
Komeno, M., Hayamizu, H., Fujita, K., & Ashida, H. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.02582-18 · Cited by 54 · cited 1×
“The initial fermentation of large cRG-I polymers by Bacteroides species likely releases cRG-I fragments that are then consumed by Bifidobacteriaceae, known degraders of arabinans and galactans, the main side chains of cRG-I [48,49].”
BackgroundA novel 3D in vitro model of the human gut microbiota
Biagini, F., Calvigioni, M., Lapomarda, A., Vecchione, A., Magliaro, C., De Maria, C., Montemurro, F., Celandroni, F., Mazzantini, D., Mattioli-Belmonte, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78591-w · Cited by 45
Gaisawat, M. B., MacPherson, C. W., Tremblay, J., Piano, A., Iskandar, M. M., Tompkins, T. A., & Kubow, S. J. (2019) · Microorganisms · doi:10.3390/microorganisms8010060 · Cited by 35
Van den Abbeele, P., Duysburgh, C., Cleenwerck, I., Albers, R., Marzorati, M., & Mercenier, A. (2021) · Microorganisms · doi:10.3390/microorganisms9102142 · Cited by 31
Self-citationDietary fiber chemical structure determined gut microbiota dynamics
Meng, X., Zheng, J., Wang, F., Zheng, J., & Yang, D. J. (2022) · iMeta · doi:10.1002/imt2.64 · Cited by 30 · cited 1×
“As demonstrated for other complex polysaccharides [51], the high complexity of the cRG-I chemical structure is likely responsible for supporting the growth of such a broad range of taxa.”
BackgroundCantu-Jungles, T. M., & Hamaker, B. R. (2020) · mBio · doi:10.1128/mbio.00747-20 · Cited by 15
Cited by
Tang, X., & de Vos, P. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2290230 · Cited by 82
Li, J., Liu, F., Luo, Y., Wijeyesekera, A., Wang, S., Chen, X., Lv, Y., Jin, J., Sheng, H.-F., Wang, G., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04189-6 · Cited by 40
Steinert, R. E., Rehman, A., Sadabad, M. S., Milanese, A., Wittwer, J., Burton, J. P., & Spooren, A. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2477816 · Cited by 38
Desai, K., den Abbeele, P. V., Duysburgh, C., Albers, R., Wennekes, T., Schols, H. A., & Mercenier, A. (2024) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2024.110036 · Cited by 22
Self-citationChristen, S., Redeuil, K. M., Goulet, L., Giner, M. P., Breton, I., Rota, R., Frézal, A., Nazari, A., den Abbeele, P. V., Godin, J., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-025-01421-8 · Cited by 31
“Microbial composition analysis was performed on 6 faecal microbiota (0 h) and 18 ex vivo incubated microbiome samples (three-study arms (NSC, NR and Nam) for 6 participants at 48 h), according to a methodology described by Van den Abbeele et al. (2023) 54 .”
Metadata
- Authors
- Van den Abbeele, P., Deyaert, S., Albers, R., Baudot, A., & Mercenier, A.
- Affiliations
- Cryptobiotix SA, 9052 Ghent, Belgium
- NutriLeads (Netherlands) (NL)
- Corresponding author
- Mercenier, Annick
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-04-26
- Volume
- 15
- Issue
- 9
- Pages
- 2090
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10180869
- OpenAlex
- W4367183657
- Cited by
- 46
- References
- 68
- Citations by year
- 2026: 16 · 2025: 17 · 2024: 10 · 2023: 3
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- NutriLeads B.V., Wageningen, The Netherlands
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- rhamnogalacturonan I, carrot, gut microbiota, interpersonal variability, prebiotics, inulin, xanthan gum, butyrate production, short-chain fatty acids, acetate, propionate, Bacteroides, Bifidobacterium, Faecalibacterium prausnitzii
- MeSH terms
- Gastrointestinal Microbiome, Adult, Bacteroides, Butyrates, Humans, Propionates, Daucus carota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.